{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:46:22Z","timestamp":1787496382943,"version":"build-2736575974"},"reference-count":25,"publisher":"Scientific Scholar","content-domain":{"domain":["ruralneuropractice.com"],"crossmark-restriction":true},"short-container-title":["JNRP"],"abstract":"\n Objectives:<\/jats:title>\n In patients with catatonia, it has been discovered that benzodiazepines (BZD) have a remarkable impact. However, there is not much evidence reflecting the long-term treatment with only BZDs before considering electroconvulsive therapy.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n One-year retrospective data of patients obtained from the health management information system (HMIS) portal and records of the department of psychiatry with the diagnosis of catatonia. This data was then analyzed for adequate history, presenting complaints, treatment taken, substance use, and was organized into five groups depending on the primary diagnosis as per the Diagnostic and Statistical Manual of Mental. The scores of Bush-Francis Catatonia Rating Scales of day 1 and subsequent follow-ups were secured. Categorical variables were analyzed with the Chi-squared test. The response overtime for all the groups and its correlation with the number of visits was compared using repeated measures analysis of variance.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n We found that the lorazepam challenge test versus improvement after 1 week of oral lorazepam had Pearson\u2019s correlation of 0.604, this correlation decreased in the following weeks. In the 3 week, the correlation was 0.373, which was statistically significant. This shows that the highest correlation was seen in the 1\n st<\/jats:sup>\n week. Hence, our study suggested that lorazepam challenge test is a good predictor of response in the 1\n st<\/jats:sup>\n week alone. We observe negative correlation which is significant in the 3\n rd<\/jats:sup>\n week (\n P<\/jats:italic>\n = 0.048) and not in the 1\n st<\/jats:sup>\n and 2\n nd<\/jats:sup>\n week.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n \n Our study analyzed the patients with catatonia in psychiatric diagnostic categories, history, and the outcome after treating them with lorazepam at every visit over 3 weeks. The correlation in the level of improvement of symptoms at subsequent visits was noteworthy and had a strong association with the lorazepam challenge test. When dose of lorazepam was tapered, on an average dose was reduced in the 2\n nd<\/jats:sup>\n week. Suggesting that at least 3 week treatment would be ideal.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.25259\/jnrp_36_2022","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T06:18:44Z","timestamp":1677133124000},"page":"258-263","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The retrospective and observational study of catatonia \u2013 Diagnosis, course of illness, and the response to lorazepam \u2013 in a tertiary health-care center"],"prefix":"10.25259","volume":"14","author":[{"given":"Rahul","family":"Latke","sequence":"first","affiliation":[{"name":"Department of Psychiatry, HBTMC and Dr. RN Cooper Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deoraj","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, HBTMC and Dr. RN Cooper Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejaswini","family":"Miskin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Sir JJ Groups of Hospitals, Mumbai, Maharashtra, India,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astik","family":"Mane","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, HBTMC and Dr. RN Cooper Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"10.25259\/JNRP_36_2022\/ref-1","author":"Kahlbaum","year":"1874","edition":"1st ed"},{"key":"10.25259\/JNRP_36_2022\/ref-2","first-page":"7","article-title":"Comparison of catatonia presentation in patients with schizophrenia and mood disorders in Lagos, Nigeria","volume":"6","author":"Usman","year":"2011","journal-title":"Iran J Psychiatry"},{"key":"10.25259\/JNRP_36_2022\/ref-3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0010-440X(03)00108-1","article-title":"Factor analysis of the catatonia rating scale and catatonic symptom distribution across four diagnostic groups","volume":"44","author":"Kr\u00fcger","year":"2003","journal-title":"Compr Psychiatry"},{"key":"10.25259\/JNRP_36_2022\/ref-4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fpsyt.2014.00174","article-title":"Prevalence of the catatonic syndrome in an acute inpatient sample","volume":"5","author":"Stuivenga","year":"2014","journal-title":"Front Psychiatry"},{"key":"10.25259\/JNRP_36_2022\/ref-5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000083964","article-title":"Catatonia: Disappeared or under-diagnosed?","volume":"38","author":"Van Der Heijden","year":"2005","journal-title":"Psychopathology"},{"key":"10.25259\/JNRP_36_2022\/ref-6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s15006-019-1173-5","article-title":"Catatonia in clinical reality: Underdiagnosed and forgotten","volume":"161","author":"Adorjan","year":"2019","journal-title":"MMW Fortschr Med"},{"key":"10.25259\/JNRP_36_2022\/ref-7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/0019-5545.75559","article-title":"Phenomenology and treatment of Catatonia: A descriptive study from north India","volume":"53","author":"Dutt","year":"2011","journal-title":"Indian J Psychiatry"},{"key":"10.25259\/JNRP_36_2022\/ref-8","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.pnpbp.2010.08.017","article-title":"Response rate of lorazepam in catatonia: A developing country's perspective","volume":"34","author":"Tibrewal","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.25259\/JNRP_36_2022\/ref-9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fpsyt.2014.00181","article-title":"A clinical review of the treatment of catatonia","volume":"5","author":"Sienaert","year":"2014","journal-title":"Front Psychiatry"},{"key":"10.25259\/JNRP_36_2022\/ref-10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1600-0447.1994.tb01515.x","article-title":"Benzodiazepines in the treatment of catatonic syndrome","volume":"89","author":"Ungvari","year":"1994","journal-title":"Acta Psychiatr Scand"},{"key":"10.25259\/JNRP_36_2022\/ref-11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/00004714-199002000-00024","article-title":"Lorazepam as an adjunct in the treatment of catatonic states: An open clinical trial","volume":"10","author":"Yassa","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"10.25259\/JNRP_36_2022\/ref-12","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"Asken","year":"2013"},{"key":"10.25259\/JNRP_36_2022\/ref-13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/schbul\/sbp141","article-title":"Catatonia and its treatment","volume":"36","author":"Rosebush","year":"2010","journal-title":"Schizophr Bull"},{"key":"10.25259\/JNRP_36_2022\/ref-14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3109\/10401230009147094","article-title":"Catatonia in a psychiatric intensive care facility: Incidence and response to benzodiazepines","volume":"12","author":"Lee","year":"2000","journal-title":"Ann Clin Psychiatry"},{"key":"10.25259\/JNRP_36_2022\/ref-15","doi-asserted-by":"publisher","first-page":"100158","DOI":"10.1016\/j.scog.2019.100158","article-title":"Determinants of occupational outcome in recent-onset psychosis: The role of cognition","volume":"18","author":"Pothier","year":"2019","journal-title":"Schizophr Res Cogn"},{"key":"10.25259\/JNRP_36_2022\/ref-16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/acps.12447","article-title":"Comparison of psychotic bipolar disorder, schizoaffective disorder, and schizophrenia: An international, multisite study","volume":"133","author":"Tondo","year":"2016","journal-title":"Acta Psychiatr Scand"},{"key":"10.25259\/JNRP_36_2022\/ref-17","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1176\/appi.ajp.2010.09101406","article-title":"Prediction of real-world functional disability in chronic mental disorders: A comparison of schizophrenia and bipolar disorder","volume":"167","author":"Bowie","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.25259\/JNRP_36_2022\/ref-18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/yct.0b013e3181587949","article-title":"Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms","volume":"23","author":"Hatta","year":"2007","journal-title":"J ECT"},{"key":"10.25259\/JNRP_36_2022\/ref-19","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1176\/appi.ajp.160.7.1233","article-title":"Catatonia in psychiatric classification: A home of its own","volume":"160","author":"Taylor","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.25259\/JNRP_36_2022\/ref-20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/jnp.23.2.jnp223","article-title":"Catatonia in psychotic patients: Clinical features and treatment response","volume":"23","author":"England","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.25259\/JNRP_36_2022\/ref-21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00787-014-0595-y","article-title":"Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia","volume":"24","author":"Raffin","year":"2015","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.25259\/JNRP_36_2022\/ref-22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/978-1-4939-2528-5_27","volume-title":"The Medical Basis of Psychiatry","author":"Dhossche","year":"2016"},{"key":"10.25259\/JNRP_36_2022\/ref-23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/15622970701287369","article-title":"Catatonia as a risk factor for the development of neuroleptic malignant syndrome: Report of a case following treatment with clozapine","volume":"10","author":"Paparrigopoulos","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"10.25259\/JNRP_36_2022\/ref-24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s002130050904","article-title":"Lorazepam for chronic catatonia: A randomized, double-blind, placebo-controlled cross-over study","volume":"142","author":"Ungvari","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.25259\/JNRP_36_2022\/ref-25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1176\/ajp.146.4.553b","article-title":"Evaluation and treatment of catatonia","volume":"146","author":"Clothier","year":"1989","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Neurosciences in Rural Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ruralneuropractice.com\/the-retrospective-and-observational-study-of-catatonia-diagnosis-course-of-illness-and-the-response-to-lorazepam-in-a-tertiary-health-care-center\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ruralneuropractice.com\/the-retrospective-and-observational-study-of-catatonia-diagnosis-course-of-illness-and-the-response-to-lorazepam-in-a-tertiary-health-care-center\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T07:42:15Z","timestamp":1683099735000},"score":1,"resource":{"primary":{"URL":"https:\/\/ruralneuropractice.com\/the-retrospective-and-observational-study-of-catatonia-diagnosis-course-of-illness-and-the-response-to-lorazepam-in-a-tertiary-health-care-center\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":25,"alternative-id":["10.25259\/JNRP_36_2022"],"URL":"https:\/\/doi.org\/10.25259\/jnrp_36_2022","relation":{},"ISSN":["0976-3155","0976-3147"],"issn-type":[{"value":"0976-3155","type":"electronic"},{"value":"0976-3147","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"article-number":"258"}}